MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC EV/EBITDA 2011-2026 | OXFD
EV/EBITDA Jährlich Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -73.4 | -11 | -8.91 | -11.9 | -7.71 | -7.65 | -0.465 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.465 | -73.4 | -17.3 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 16.87 | -1.86 % | $ 181 M |  China |
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
27.4 | $ 116.31 | 3.68 % | $ 35.4 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 20.92 | -0.21 % | $ 1.11 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.62 | $ 1.61 | 2.55 % | $ 2.14 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 25.19 | -1.29 % | $ 700 M | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 14.62 | -3.31 % | $ 442 M | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
38 | $ 113.81 | 1.64 % | $ 9.39 B |  Irlanda |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
70.5 | $ 137.81 | -1.12 % | $ 21.9 B | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 86.76 | -1.16 % | $ 5.86 B | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 4.97 | 0.51 % | $ 460 M | USA |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
-33.5 | $ 8.97 | -0.33 % | $ 1.15 B | USA |
 |
Medpace Holdings
MEDP
|
30.7 | $ 420.37 | 0.8 % | $ 12.1 B | USA |
 |
National Research Corporation
NRC
|
21 | $ 18.89 | 3.68 % | $ 423 M | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 175.64 | 1.93 % | $ 8.71 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
55.6 | $ 26.53 | 1.11 % | $ 20 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
-28.8 | $ 89.86 | -1.44 % | $ 11.3 B | USA |
 |
Personalis
PSNL
|
-7.07 | $ 5.82 | -1.36 % | $ 345 M | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | Israel |
 |
Thermo Fisher Scientific
TMO
|
19.3 | $ 465.84 | 0.71 % | $ 176 B | USA |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 2.0 | -5.66 % | $ 8.85 M | USA |
 |
Senseonics Holdings
SENS
|
-13.8 | $ 4.84 | -3.39 % | $ 202 M | USA |
 |
Soleno Therapeutics
SLNO
|
0.12 | $ 52.91 | 0.02 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-6.24 | $ 2.17 | 0.46 % | $ 4.98 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-23.6 | $ 58.74 | 4.54 % | $ 3.51 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 253.69 | 0.27 % | $ 21.1 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 144.16 | -0.57 % | $ 6.74 B | USA |
 |
Natera
NTRA
|
-19.5 | $ 208.31 | -1.47 % | $ 20.5 B | USA |
 |
Neogen Corporation
NEOG
|
40.3 | $ 9.27 | 1.98 % | $ 2.01 B | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 190.65 | -0.44 % | $ 21.2 B | USA |
 |
Waters Corporation
WAT
|
24.6 | $ 341.0 | 12.96 % | $ 20.3 B | USA |